Cosmo Pharmaceuticals NV (CHIX:COPNZ) Dividend Payout Ratio : 15.06 (As of Jun. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Cosmo Pharmaceuticals NV Dividend Payout Ratio?

Cosmo Pharmaceuticals NV's dividend payout ratio for the months ended in Jun. 2023 was 15.06.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Cosmo Pharmaceuticals NV is 1.62, which seems too high.

The historical rank and industry rank for Cosmo Pharmaceuticals NV's Dividend Payout Ratio or its related term are showing as below:

CHIX:COPNz' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.81 Med: 0.91 Max: 1.62
Current: 1.62

During the past 13 years, the highest Dividend Payout Ratio of Cosmo Pharmaceuticals NV was 1.62. The lowest was 0.81. And the median was 0.91.

CHIX:COPNz's Dividend Payout Ratio is ranked worse than
96.03% of 428 companies
in the Drug Manufacturers industry
Industry Median: 0.335 vs CHIX:COPNz: 1.62

As of today (2024-05-12), the Dividend Yield % of Cosmo Pharmaceuticals NV is 1.45%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Cosmo Pharmaceuticals NV was 2.77%. The lowest was 0.68%. And the median was 1.28%.

Cosmo Pharmaceuticals NV's Dividends per Share for the months ended in Jun. 2023 was CHF1.02.

During the past 12 months, Cosmo Pharmaceuticals NV's average Dividends Per Share Growth Rate was 5.10% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Cosmo Pharmaceuticals NV was 13.40% per year. The lowest was 13.40% per year. And the median was 13.40% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Cosmo Pharmaceuticals NV Dividend Payout Ratio Historical Data

The historical data trend for Cosmo Pharmaceuticals NV's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cosmo Pharmaceuticals NV Dividend Payout Ratio Chart

Cosmo Pharmaceuticals NV Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dividend Payout Ratio

Get a 7-Day Free Trial

0.91

Cosmo Pharmaceuticals NV Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Dividend Payout Ratio	Get a 7-Day Free Trial															-	-	1.98	-	15.06

Competitive Comparison of Cosmo Pharmaceuticals NV's Dividend Payout Ratio

For the Drug Manufacturers - General subindustry, Cosmo Pharmaceuticals NV's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cosmo Pharmaceuticals NV's Dividend Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cosmo Pharmaceuticals NV's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Cosmo Pharmaceuticals NV's Dividend Payout Ratio falls into.

Cosmo Pharmaceuticals NV Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Cosmo Pharmaceuticals NV's Dividend Payout Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Dec. 2022 )	/	EPS without NRI (A: Dec. 2022 )
	=	0.938	/	1.036
	=	0.91

Cosmo Pharmaceuticals NV's Dividend Payout Ratio for the quarter that ended in Jun. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Jun. 2023 )	/	EPS without NRI (Q: Jun. 2023 )
	=	1.024	/	0.068
	=	15.06

Cosmo Pharmaceuticals NV (CHIX:COPNz) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Cosmo Pharmaceuticals NV Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Cosmo Pharmaceuticals NV's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Cosmo Pharmaceuticals NV (CHIX:COPNZ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cosmo Pharmaceuticals NV (CHIX:COPNz) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

CMOPF:USA C43:Germany COPN:Switzerland

Address

Sir John Rogerson’s Quay, Riverside II, Dublin, IRL, 2

Website

https://www.cosmopharma.com

Cosmo Pharmaceuticals NV is a pharmaceutical company with a focus on gastrointestinal diseases, dermatology and healthtech. The company develops and manufactures products that are distributed globally by its partners. Products that the company has developed include Lialda/Mezavant/Mesavancol and Uceris/Cortiment, for the treatment of ulcerative colitis; GI Genius, which uses artificial intelligence to aid the detection of colorectal polyps during colonoscopy; Eleview, a submucosal injectable composition for use in gastrointestinal endoscopic procedures; Aemcolo for the treatment of travellers' diarrhoea (TD) and Winlevi for the treatment of acne. Product pipeline includes Breezula, GI Genius, Methylene blue MMX, Aemcolo, CB-03-10 and CB-01-33.

Cosmo Pharmaceuticals NV (CHIX:COPNZ) Headlines

No Headlines